Research and Development

Showing 15 posts of 9596 posts found.

covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 24, 2020 Research and Development COVID, COVID-19, coronavirus

Coronavirus news this week sees treatments for existing diseases being tested in COVID-19 patients, with Roche’s rheumatoid arthritis drug Actemra …
johnsons_baby_powder_massage

Johnson & Johnson loses bid to overturn baby powder cancer case

June 24, 2020 Research and Development Johnson and Johnson, talc, talc powder

Johnson & Johnson have had a bid to overturn a verdict that blamed the company’s baby powder for giving women …
home_office

UK Home office reclassifies Epidyolex as a Schedule 5 drug

June 24, 2020 Research and Development CBD, cannabiodiol, cannabis

The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …
gilead-sciences

Gilead to investigate inhaled formulation of promising COVID-19 therapy remdesivir

June 23, 2020 Manufacturing and Production, Research and Development COVID-19, Gilead, remdesivir

Gilead is intent on pushing the applications of its antiviral drug remdesivir after it has shown efficacy in the treatment …
pexels-photo-3044623_araruna

How is COVID-19 impacting the rare disease community?

June 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
shutterstock

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …

Roche’s rheumatoid arthritis drug Actemra shows no benefit in COVID-19 pneumonia

June 18, 2020 Research and Development Actemra, COVID-19, Roche, coronavirus

Hope is waning around the efficacy of Roche’s Actemra (tocilizumab) following the release of results from an Italian study focusing …

FDA approval for Jazz and PharmaMar’s Zepzelca in metastatic small cell lung cancer

June 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, FDA, PharmaMar, Zepzelca, jazz pharma, lung cancer

The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …
type_2

New data from diabetes prevention programme shows a reduction of type 2 diabetes

June 17, 2020 Research and Development diabetes, type 2 diabetes

The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …
dexamethasone_matthew_horwoodgetty_images

Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support

June 17, 2020 Research and Development COVID-19, University of Oxford, coronavirus, dexamethasone

The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical …
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 17, 2020 Research and Development COVID-19, coronavirus, coronavirus roundup

There is a fear of a second wave of coronavirus coming out of China, as the country reported its highest …

HPV vaccine approved by FDA to prevent throat cancer

June 17, 2020 Research and Development HPV, HPV STI, HPV vaccine

The HPV (human papillomavirus) vaccine Gardasil 9 has been approved by the FDA to prevent HPV-related genital tract, agnogenital infections …
sinovac

Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2

June 16, 2020 Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma

As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …
The Gateway to Local Adoption Series

Latest content